Topic:
Discovery IT
Latest Headlines
Latest Headlines
Boehringer Ingelheim goes to Hungary for R&D software
ChemAxon has fattened its pharma business, landing a deal with German drug powerhouse Boehringer Ingelheim. Budapest-based ChemAxon announced Feb. 14 that the drugmaker plans to use its chemistry software platform in the process of ushering compounds from discovery to the clinic.
European drug discovery platform emerges in €196M effort
Europe's pharma community is revving up a drug discovery engine. A new effort involving 30 partners--including Bayer, Johnson & Johnson's Janssen and 5 other large pharmas--has launched to spark discovery of new treatments, using a crowdsourcing and open-innovation approach.
Hopkins mines Twitter for real flu cases in real time
As flu infiltrates our homes and workplaces, researchers have developed a computer-based method of tracking Twitter posts that could alert the public to sickness faster than official health reports with greater accuracy than existing online tools.
Link between weather, disease drives new prediction outbreak models
Just as news channels use computer models to forecast weather, data on weather conditions might also be helpful in predicting disease outbreaks.
iPad app garners kudos for boosting lab productivity
BioData picked up a nod from The Scientist for its web application called Labguru. Named among the magazine's Top 10 Innovations of 2012, the app offers scientists the ability to manage their lab work on their desktop or iPad easily and inexpensively.
How lessons from iPhone's Siri aid biological exploration
For all the genomic data available to the scientific community, many biological functions remain mysterious to researchers. A group from the University of California, San Diego School of Medicine has tested the use of bioinformatics and other technologies to demystify how cells function.
Titan takes over as world's top supercomputer
As biotech research becomes more of a computational endeavor, it's worth paying attention to the arms race of sorts for the world's fastest supercomputers.
Database aims to speed discoveries for blood cancer treatments
Academic and industry researchers could tap the data set to seek individualized treatments, diagnostics and targets for new therapies against cancer.
Eisai's H3 Bio leans on bioinformatics as cancer researcher expands
H3 Biomedicine has doubled its research space in Cambridge, MA, and expects its staff to undergo equivalent growth. Its bioinformatics pros are mining data in pursuit of new therapies for cancer.
NIH taps Northrop Grumman for $30M bioinformatics project
The National Institutes of Health has picked Northrop Grumman to be the major government contractor for an IT and bioinformatics project for helping researchers gather, analyze and exchange data from immunology studies.
